Difficult-to-treat and severe asthma: changing the paradigm (webinar)

Learning outcomes

Upon completion of this module the learner will be able to:

Privacy | Copyright | Terms of use

© 2018 National Prescribing Service Limited. This program is joint-funded by AstraZeneca Pty Ltd and Novartis Pharmaceuticals Australia Pty Ltd and managed by VentureWise, a wholly owned commercial subsidiary of NPS MedicineWise. The content has been designed, developed and delivered by NPS MedicineWise with complete independence and editorial control, based on best practice guidelines.